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Abstract 
Since genes associated with similar diseases/disorders show an increased tendency for their 
protein products to interact with each other through protein–protein interactions (PPI), 
clustering analysis obviously as an efficient technique can be easily used to predict human 
disease-related gene clusters/subnetworks. Firstly, we used clustering algorithms, Markov 
cluster algorithm (MCL), Molecular complex detection (MCODE) and Clique percolation 
method (CPM) to decompose human PPI network into dense clusters as the candidates of 
disease-related clusters, and then a log likelihood model that integrates multiple biological 
evidences was proposed to score these dense clusters. Finally, we identified disease-related 
clusters using these dense clusters if they had higher scores. The efficiency was evaluated by a 
leave-one-out cross validation procedure. Our method achieved a success rate with 98.59% 
and recovered the hidden disease-related clusters in 34.04% cases when removed one known 
disease gene and all its gene-disease associations. We found that the clusters decomposed by 
CPM outperformed MCL and MCODE as the candidates of disease-related clusters with 
well-supported biological significance in biological process, molecular function and cellular 
component of Gene Ontology (GO) and expression of human tissues. We also found that 
most of the disease-related clusters consisted of tissue-specific genes that were highly ex-
pressed only in one or several tissues, and a few of those were composed of housekeeping 
genes (maintenance genes) that were ubiquitously expressed in most of all the tissues.  
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Introduction 
With the increase in availability of human pro-
tein  interaction  data  and  gene  expression  data,  the 
focus of bioinformatics development has shifted from 
understanding networks encoded by model species to 
understanding the networks underlying human dis-
ease  [1].  Predicting  human  disease-related  clus-
ters/subnetworks  using  a  biomolecular  network  is 
critical to gain an understanding of disease mechan-
isms, and is also essential for the development of new 
diagnostics  and  therapeutics.  Subnetworks  are  of 
great importance because they not only provide con-
crete hypotheses as to the molecular complexes, sig-
naling  pathways,  but  also  offer  mechanistic  hypo-
theses about the causes of disease [2].  
Integrating known disease genes with physical 
or biomolecular networks and gene expression data to 
identify disease-related subnetworks can help us ex-
plain  many  genetic  and  environmental  factors  in-
fluencing a disease in the context of a smaller number 
of discrete subnetworks as well as the causes or effects 
of the disease phenotype. In recent years, many stu-
dies had shown the utility of these networks in ex-
tracting disease-related clusters/subnetworks [2] and 
inferring disease-causing genes [2, 7-11]. Qiu et al. [3] 
proposed  a  method  to  detect  disease-related  gene 
modules or dysfunctional pathways based on global 
characteristics of interactome coupled with gene ex-
pression  data.  The  modules  or  pathways  were  in-
ferred  based  on  gene‟s  active  score  function  which 
was defined based on the kernel trick. They applied 
the proposed method to two cancer related problems, 
i.e. breast cancer and prostate cancer, and successfully Int. J. Biol. Sci. 2011, 7 
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identified active modules or dysfunctional pathways 
related to these two types of cancers with literature 
confirmed  evidences.  Karni  et  al.  [4]  presented  an 
approach to causal gene prediction that was based on 
integrating  PPI  network  data  with  gene  expression 
data  under  a  condition  of  interest.  They  applied  a 
set-cover-like heuristic to identify a small set of genes 
that best “cover” the disease-related genes and pre-
dicted possible genes that were involved in myasthe-
nia gravis. Calvano et al. [5] assembled an endotoxin 
inflammatory response network by integrating func-
tional  interactions  curated  from  the  literature  with 
gene expression information. The response network 
enabled  the  identification  of  new  endotox-
in-responsive  modules.  Ghazalpour  et  al.  [6]  con-
structed a gene coexpression network using microar-
ray  profiles  gathered  from  the  livers  of  a  panel  of 
mice, and plenty of subnetworks in the network were 
extracted to be enriched for genes in loci with strong 
associations to a physiological trait, yielding a matrix 
of module/trait associations. Lage et al. [12] devised a 
phenotype  similarity  score  and  used  it  to  look  for 
protein complexes whose genes were associated with 
similar  phenotypes.  Similarly,  Fraser  et  al.  [13] 
showed  that  identifying  human  protein  complexes 
containing known disease genes was an efficient me-
thod for large-scale disease gene discovery.  
In contrast to the above studies, Goh et al. [14] 
built a network of human disease/ human gene asso-
ciations, which was a bipartite graph consisting of two 
disjoint  sets  of  nodes.  One  set  corresponded  to  all 
known genetic disorders, whereas the other set cor-
responded to all known disease genes in the human 
genome. A disorder and a gene were then connected 
by a link if mutations in that gene were implicated in 
that disorder. They found that disease genes causing 
similar diseases exhibited an increased tendency for 
their  protein products to interact with one another, 
and tend to be coexpressed in specific tissues [2]. 
Combining these network-based disease studies, 
the  overriding  conclusion  is  that  genes  associated 
with a particular disease tend to exhibit high connec-
tivity  and  cluster  together  [2,  14,  15,  16].  Thus,  the 
hypothesis  is  that  disease  genes  within  such  dense 
clusters in a biomolecular network that more likely 
interact with one another than with others often cause 
similar diseases and is becoming an increasingly sig-
nificant  factor  for  hunting  human  disease-related 
gene clusters/subnetworks.  
In this paper, we tackled the prediction problem 
by clustering analysis integrating PPI networks and 
gene  expression  data,  and  superimposing  a  set  of 
known disease genes on human PPI network in a dif-
ferent  way.  Firstly,  we  used  clustering  algorithms, 
Markov cluster algorithm (MCL) [22, 23], Molecular 
complex detection (MCODE) [21] and Clique percola-
tion  method  (CPM)  [24]  to  decompose  human  PPI 
network into dense clusters, and then a log likelihood 
model  that  integrates  multiple  biological  evidences 
was proposed to score these dense clusters. Finally, 
we  identified  disease-related  clusters  using  these 
dense clusters if they had higher scores. The efficiency 
was  evaluated  by  a  leave-one-out  cross  validation 
procedure. In addition, we also gave a comparison of 
the clusters decomposed by MCL, MCODE and CPM 
as the candidates of disease-related clusters. 
Materials and Methods 
Biological Data 
The disease genes data was obtained from Goh 
et al. [14], and they collected the data from the Online 
Mendelian  Inheritance  in  Man  (OMIM)  [17]  which 
contains 1284 disorders and 1777 disease genes. Fur-
ther,  they  classified  each  disorder  into  22  primary 
disease/disorder classes manually based on the phy-
siological system affected by the disorder. 
The  human  protein-protein  interaction  (PPI) 
data was also gained from Goh et al. [14], and they 
combined  two  high  quality  systematic  yeast 
two-hybrid experiments [18, 19] with PPIs obtained 
from  literature  by  manual  curation  [18].  The  inte-
grated set of PPIs contains 22052 non-self-interacting, 
non-redundant interactions between 7533 genes. 
The used gene expression microarray data was 
from Ge et al. [20], which is available for 36 normal 
human  tissues.  A  gene  is  considered  to  be  “ex-
pressed” if the P-value associated with its transcript 
abundance is less than the threshold, P-value<0.02. A 
gene is considered as housekeeping  gene (mainten-
ances gene) if it is expressed, and confidently detect-
able (P-value<0.01) in most human tissues [20]. 
Clustering Algorithms 
Three classic clustering algorithms used to de-
compose the human PPI networks into dense clusters 
are shown in the following: 
Molecular  complex  detection  (MCODE)  pro-
posed by Bader and Hogue [21] was an effective ap-
proach  for  detecting  densely-connected  regions  in 
large PPI networks. MCODE made use of local graph 
density to find protein complex. PPI networks were 
transformed  to  weighted  graphs  in  which  vertices 
were proteins and edges represented protein interac-
tions. The algorithm operated in three stages: vertex 
weighting,  complex  prediction  and  optimal 
post-processing.  First  it  assigned  a  weight  to  each 
vertex, corresponding to its local neighborhood den-
sity. Then, starting from the top weighted vertex (seed Int. J. Biol. Sci. 2011, 7 
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vertex),  it  recursively  moved  outward,  including  in 
the cluster vertices whose weight was above a given 
threshold.  This  threshold  corresponded  to  a  us-
er-defined percentage of the weight of the seed vertex. 
The  results  showed  that  MCODE  effectively  found 
densely-connected regions of a molecular interaction 
network solely based on connectivity data. Many of 
these regions corresponded to the known molecular 
complexes. 
Markov cluster algorithm (MCL) [22, 23] was a 
fast and scalable unsupervised clustering algorithm. It 
was designed to meet the challenge of finding cluster 
structure in simple and weighted graphs. The MCL 
algorithm simulated random walks within a graph by 
the alternation of expansion and inflation operations. 
Expansion referred to taking the power of a stochastic 
matrix  using  the  normal  matrix  product.  Inflation 
corresponded  to  taking  the  Hadamard  power  of  a 
matrix, followed by a scaling step, so that the result-
ing matrix was again stochastic. Eventually, iterating 
expansion and inflation resulted in the separation of 
the graph into different segments.  
A  novel  network  clustering  method,  Clique 
Percolation  Method  (CPM)  was  proposed  to  reveal 
the  overlapping  modules  in  PPI  networks  [24].  In 
CPM, a module was defined as a union of all k-cliques 
(complete  subgraph  of  size  k)  that  can  be  reached 
from each other through a series of adjacent k-cliques 
(where  adjacency  means  sharing  k-1  nodes).  This 
method  performed  well  in  detecting  overlapping 
functional modules/protein complexes. 
Evaluating Criteria 
Disease Related Coefficient (DisRC) is used to eva-
luate  the  degree  of  the  cover  between  the  clusters 
decomposed  from  human  PPI  network,  and  the 
classes of disease associated genes.  
| | | |
( ) ( )
||
i CD
DisRC C Max
C

            …(1) 
where, C is the set of genes of a cluster; Di is the 
set of genes that causing disease, i. |C| and |Di| de-
note the number of genes in C and Di respectively. 
DisRC(C)  equals  the  maximal
| | | |
||
i CD
C

that 
represents the “best cover”, and C is assigned to the 
corresponding disease class. 
Since disease associated genes which more likely 
interact  with  each  other  often  lead  to  similar  dis-
ease/disorder, a group of genes associated with the 
same disease/ disorder should share similar cellular 
and functional characteristics, as annotated in Gene 
Ontology (GO) [14, 27]. To investigate its validity, we 
introduced  the  Biological  Process  Related  Coefficient 
(BPRC), Molecular Function Related Coefficient (MFRC) 
and Cellular Component Related Coefficient (CCRC) of a 
disease-related cluster, defined as the maximum frac-
tion  of  genes  among  those  belonging  to  a  dis-
ease-related cluster that had same GO annotation in 
biological  process,  molecular  function  and  cellular 
component  respectively.  Using  these  criteria,  we 
measured  the  consistency  of  each  disease-related 
cluster separately with each branch of GO, biological 
process, molecular function, and cellular component.  
BPRC, MFRC and CCRC are used to score the 
consistency of genes within disease-related clusters in 
GO annotations respectively. 
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where,  tjBP denotes  the  number  of  genes  have 
same GO annotation, j in biological process. tjMF and 
tjCC are similar to tjBP.  
Disease  genes  encoding  proteins  that  interact 
highly with each other tend to be coexpressed in the 
same human tissues. To measure this, we introduced 
the Tissue-Related Coefficient (TRC) of a disease-related 
cluster,  defined  as  the  maximum  fraction  of  genes 
among  those  belonging  to  a  disease-related  cluster 
that were coexpressed in a specific tissue [14, 20].  
TRC quantifies whether genes that are in a dis-
ease-related cluster tend to be coexpressed in similar 
human tissues. 
( ) ( )
||
t n
TRC C Max
C
            …(5) 
where, nt denotes the number of genes, that are 
coexpressed in the tissue, t. If all the genes are coex-
pressed together in at least one tissue, the maximal 
value is 1; the minimum value is
1
|| C
, when all are 
coexpressed in different tissues [14]. 
Our Method 
The input to a disease-related cluster prediction 
problem consists of a human PPI network, the classes 
of known disease genes based on physiological sys-
tem  affected,  and  gene  expression  microarray  data. 
The goal is to identify disease-related clusters.  Int. J. Biol. Sci. 2011, 7 
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Since  genes  associated  with  similar  diseas-
es/disorders  show  an  increased  tendency  for  their 
protein products to interact with each other through 
PPIs,  we  decomposed  the  human PPI network  into 
dense  clusters  by  clustering  algorithms  (MCL, 
MCODE  and  CPM)  as  the  candidates  of  dis-
ease-related  clusters.  In  order  to  extract  dis-
ease-related  clusters  from  these  candidate  clusters 
and  evaluate  the  statistical  significance  of  the  dis-
ease-related clusters in multiple biological evidences, 
we gave a log likelihood model that was similar to 
that  recently  proposed  by  Sharan  et  al.  [28,  29]  to 
measure  the  fit  of  the  candidate  cluster  to  a  dis-
ease-related cluster. 
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;  the 
genes within a candidate cluster interact with a high 
probability α, and this cluster may be suggested as a 
disease-related cluster that is not random; β,γ are the 
tuning  parameters  that  are  used  for  normalization; 
wi=1/|T|; 
T={DisRC(C);BPRC(C);MFRC(C);CCRC(C);TRC(C)}. 
This  model  integrates  multiple  biological  evi-
dences in  T to  score  the statistical  significance  of a 
disease-related cluster. For each candidate cluster C, 
we calculated the L(C) of the cluster related to a spe-
cific  disease,  and  assigned  it  to  the  corresponding 
disease that received the maximal value. A group of 
genes with a higher score is more significant corres-
ponding to a disease-related cluster than the one with 
a smaller score.  
Eq. 6 can be simplified in the following:  
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Here,  the α was set to 0.9 [28, 29] , and β,γ=2; 
DisRC ≥ 0.5 which kept 50% genes out of the candi-
date clusters were known disease genes involving in 
specific  disease.  We  finally  filtered  these  candidate 
clusters with L(C) ≥ 0.5 to ensure the statistical signi-
ficance of disease-related clusters in multiple biolog-
ical evidences. 
Results  
Disease-Related Clusters Detection 
The  biological  data  involving  in  disease  genes 
data, human PPI data and gene expression data used 
by our method for disease-related clusters detection 
have  been  discussed  beforehand.  The  three  classic 
clustering  algorithms:  MCODE  (Parameters:  Include 
Loops:  false,  Degree  Cutoff:  2,  Node  Score  Cutoff:  0.2, 
Haircut:  true,  Fluff:  false, K-Core: 2, Max. Depth from 
Seed: 100), MCL (Expand: 2.0, Inflation: 2.0) and CPM 
(3-clques) can be found in the above section. Since our 
method  for  disease-related  clusters  detection  made 
use of the dense clusters decomposed by these clus-
tering  algorithms  from  the  human  PPI  network,  in 
this section, we evaluated our method„s performance 
based  on  the  candidate  clusters  from  each  of  these 
clustering  algorithms  respectively,  and  by  the  way, 
compared these clustering algorithms‟ performance. 
 
Table 1 The results for detecting disease-related clusters 
based on the log likelihood model. 
Methods No. of clus-
ters 
No. of disease-related clusters  
  cluster size ≥ 
3 
L(C) ≥0.5  Max L(C)  Min L(C)  Avg. L(C) 
CPM  350  47  1.0  0.506  0.747 
MCODE  49  1  0.619  0.619  0.619 
MCL  1021  44  1.0  0.510  0.689 
 
 
In  the  table,  our  method  detected  47 
(47/350=13.43%)  disease-related  clusters  from  350 
candidate clusters of CPM with L(C) ≥0.5. Similarly, 
one  (1/49=2.04%)  disease-related  cluster  from  49 
candidate  clusters  of  MCODE,  and  44 
(44/1021=4.31%)  disease-related  clusters  from  1021 
candidate  clusters  of  MCL  were  discovered  respec-
tively. The L(C) = 1.0 means that the disease-related 
clusters achieve perfect support in multiple biological 
evidences (DisRC, BPRC, MFRC, CCRC, TRC=1.0, si-
multaneously). 
Fig. 1  showed  the  L(C)  of  each  disease-related 
cluster  in  an  ascending  order.  From  the  figure,  we Int. J. Biol. Sci. 2011, 7 
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found  that  most  of  the  disease-related  clusters  ob-
tained  from  the  candidate  clusters  of  CPM  gained 
higher  L(C)  than  MCL,  it  was  similar  to  the  mean 
value of L(C). Since only one disease-related cluster 
was acquired from the candidate clusters decomposed 
by MCODE, we only discussed MCL and MCODE in 
this section. 
Leave-One-Out Cross Validation 
To evaluate the performance of our method, we 
employed a leave-one-out cross validation procedure 
[29].  In  each  cross  validation  trial,  we  selected  k 
known  disease  genes  that  associated  with  dis-
ease-related  clusters  (128  known  disease  genes  are 
associated  with  47  disease-related  clusters  of  CPM; 
130 known disease genes are associated with 44 dis-
ease-related clusters of MCL, these k known disease 
genes are uniformly distributed in the detected dis-
ease-related  clusters)  with  equiprobability  and  re-
moved all the gene-disease associations involving the 
genes from the data, and our method was evaluated 
by its success in identifying the disease-related clus-
ters  that  had  been  hidden.  Given  that  the  dis-
ease-related clusters detected above were the putative 
disease-related clusters. A disease-related cluster was 
correctly identified if it was assigned to a same dis-
ease with the above section. Here, we validated our 
method  to  use  the  disease-related  clusters  data  de-
tected from the candidate clusters of CPM and MCL 
respectively. 
We  evaluated  our  method‟s  performance  in 
terms of precision versus recall when considering var-
ious values of k (k= 15,…,1). Precision is the fraction of 
true  disease-related  clusters  that  are  correctly  de-
tected in the corresponding trial of the cross valida-
tion procedure. Recall is the fraction of trials in which 
the  hidden  disease-related  clusters  were  recovered. 
The results were depicted in Fig. 2. For k=1, in using 
disease-related  clusters  identified  from  candidate 
clusters of CPM, our method achieved a success rate 
with 98.59% and recovered the hidden disease-related 
clusters in 34.04% cases when removed one  known 
disease gene and all its gene-disease associations. Si-
milarly,  in  using  disease-related  clusters  identified 
from  candidate  clusters of  MCL: Precision  = 98.45% 
and Recall = 31.81%. For 1≤k≤15, we found that the 
higher the value of k, the lower the value of Precision 
and Recall.  
 
 
Fig.1 The L(C) of these disease-related clusters in an ascending order. The black line in the purple pane denotes the mean 
value of the L(C). 
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Fig. 2 The leave-one-out cross validation for disease-related clusters detection. The figure shows recall versus precision 
when considering various values of k. 
 
Statistical Analysis 
Table 2 showed the results of the disease-related 
clusters with different criteria. In the table,  the dis-
ease-related  clusters  detected  from  the  candidate 
clusters  of  CPM  obtained  better  performance  than 
MCL  in  DisRC  (0.715>0.696),  BPRC  (0.895>0.805), 
MFRC  (0.697>0.630),  CCRC  (0.770>0.733)  and  TRC 
(0.839>0.771). In these criteria,  the minimal  average 
value  was  0.630  in  MFRC,  which  showed  better 
enrichment in multiple biological evidences. 
 
Table 2 The Comparison of disease-related clusters de-
tection. 
Methods  No. of dis-
ease-related 
clusters 
Avg. 
  L(C) ≥0.5  DisRC  BPRC  MFRC  CCRC  TRC 
CPM  47  0.715  0.895  0.697  0.770  0.839 
MCL  44  0.696  0.805  0.630  0.733  0.771 
 
 
Fig. 3 presented the results of the disease-related 
clusters  at  each  disease  class.  In  Fig.  3A,  11  dis-
ease-related clusters out of 47 associated with disease 
class: Immunological were detected that was more than 
other disease classes in CPM. Similarly, In Fig. 3B, 5 
disease-related  clusters  out  of  44  related  to  disease 
class: Multiple was in MCL. From Fig. 3C and Fig. 3D, 
in most of the disease classes, we found that the av-
erage  value  of  each  criterion  was  above  0.6  which 
denoted the higher homogeneity of the genes within 
these  disease-related  clusters  in  biological  process, 
molecular  function  and  cellular  component  of  GO, 
and expression in the same human tissues.  
The distribution of disease-related clusters was 
showed in Fig. 4. From Fig. 4A and Fig. 4B, we found 
that  a  common  feature  that  most  of  disease-related 
clusters  were  distributed  in  DisRC,  BPRC,  MFRC, 
CCRC, TRC  [0.6, 0.8), and =1.0, and a few of those 
were in DisRC, BPRC, MFRC, CCRC, TRC  [0.8, 0.1). 
In particular, almost 50% of disease-related clusters 
were  in  BPRC,  MFRC,  CCRC,  TRC  =1.0,  which 
showed  that  the  genes  within  these  disease-related 
clusters won perfect biological significance in biolog-
ical process, molecular function and cellular compo-
nent,  and  expression  in  the  same  human  tissues.  It 
was in contrast to L(C), most of disease-related clus-
ters were concentrated in L(C)  [0.6, 0.8) and  [0.8, 
0.1), and a few of those were in L(C) =1.0. Since L(C) 
was  an  integrated  evaluating  criterion  of  DisRC, 
BPRC, MFRC, CCRC, TRC, it had a different distribu-
tion.  
 Int. J. Biol. Sci. 2011, 7 
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Fig. 3 The results of disease-related clusters at each disease class. 
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Fig. 4 The distribution of disease-related clusters at each evaluating criterion. 
 
 
 
Tissue-specific genes are only coexpressed in one 
or several organ, which is in contrast to housekeeping 
genes  (maintenance  genes)  that  are  ubiquitously 
coexpressed  in  almost  tissues  [25,  26].  Maintenance 
genes play key roles in various cellular process, tis-
sue-specific  genes  are  related  to  the  functioning  of 
different organs. Knowing how genes are expressed 
in normal tissues not only is of fundamental impor-
tance for functional genomics, but also might contri-
bute to the study of complex diseases [4, 20, 25, 26].  
In the results, most of the disease-related clusters 
consisted of tissue-specific genes, and a few of those 
were composed of housekeeping genes (maintenance 
genes). For example, 9 (9/47=19.15%) disease-related 
clusters out of 47 consisted of housekeeping genes in 
CPM,  and  5  (5/44=11.36%)  disease-related  clusters 
out of 44 were composed of housekeeping genes in 
MCL.  
Fig. 5 showed two disease-related consisting of 
tissue-specific genes and their corresponding diseas-
es. In Fig. 5B, this disease-related cluster caused Can-
cer  with  DisRC=1,  BPRC=1,  MFRC=1,  CCRC=1  and 
TRC=1,  which  acquired  perfect  biological  signific-
ances. Fig. 6 showed a disease-related cluster that was 
composed  of  housekeeping  genes  (maintenance 
genes)  (see Fig.  6A).  From  Fig.  6B  and  Fig. 6C,  we 
found that the genes within this disease-related clus-
ter were coexpressed in most of human tissues with 
P-value <0.01. 
 Int. J. Biol. Sci. 2011, 7 
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Fig. 5 Two disease-related clusters consisting of tissue-specific genes, the red nodes denote genes, and the links between 
them represent interactions, the emerald green nodes are disease IDs, and the links between them shows they share at least 
one common disease genes. The link between a gene and a disease ID represents that the gene leads to this disease. The 
table in the bottom shows the details about diseases, one gene may lead to multiple diseases. Int. J. Biol. Sci. 2011, 7 
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Fig. 6 One disease-related cluster consisting of housekeeping genes (maintenance genes). (A) the disease-related cluster 
and their corresponding disease; (B) the expression levels of the genes in the disease-related cluster; (C) the detected 
P-value of each gene in human tissues. Note that the maintenances genes should be confidently detectable (P-value<0.01) in 
most tissues. Int. J. Biol. Sci. 2011, 7 
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Analysis of Disease-Related Clusters 
In  the  results  of  our  experiments,  we  found  a 
disease-related cluster (PEX1, PEX6, PEX26) involv-
ing in disease class, Multiple was detected from both 
the  candidate  clusters  of  CPM  and  MCL  with  L(C) 
=1.0. The  PEX1 leads to Zellweger_syndrome (OMIM 
ID: 266510), Refsum disease (OMIM ID: 214100), Adre-
noleukodystrophy  (OMIM  ID:  202370).  Similarly,  the 
PEX6  results  in  Peroxisomal_biogenesis_disorder,  and 
the PEX26 causes Zellweger_syndrome, Refsum disease, 
Adrenoleukodystrophy. The proteins within this cluster 
are also enriched with GO terms: protein import into 
peroxisome matrix (P-value = 1.38e-09), protein tar-
geting  to  peroxisome  (P-value  =  4.19e-09),  perox-
isomal  transport  (P-value  =  5.23e-09)  of  biological 
process, and protein C-terminus binding (P-value = 
5.01e-06),  protein  complex  binding  (P-value  = 
2.42e-05)  of  molecular  function,  and  peroxisomal 
membrane  (P-value  =  1.11e-07),  microbody  mem-
brane (P-value = 1.11e-07), microbody part (P-value = 
2.13e-07) of cellular component. 
The disease-related clusters (CEBPA, CTNNB1, 
TCF1) (see Fig. 5B) associated with disease class, Can-
cer was obtained from the candidate clusters of CPM 
with L(C) =1.0. The CEBPA is a causal gene of Leuke-
mia, acute myeloid (OMIM  ID:  601626),  the  CTNNB1 
causes Colorectal cancer, Hepatoblastoma, Hepatocellular 
carcinoma (OMIM ID: 114550), Ovarian carcinoma, Pi-
lomatricoma (OMIM ID: 132600), and the TCF1 is asso-
ciated with Diabetes mellitus, insulin-dependent (OMIM 
ID:  222100),  Diabetes  mellitus,  noninsulin-dependent 
(OMIM  ID:  125853),  Hepatic  adenoma  (OMIM  ID: 
142330),  MODY,  type  III  (OMIM  ID:  600496).  This 
cluster (CEBPA, CTNNB1, TCF1) is also abounded in 
GO terms: liver development (P-value = 0.00099) of 
biological  process,  and  specific  RNA  polymerase  II 
transcription  factor  activity  (P-value  =  0.00023)  of 
molecular function, and transcription factor complex 
(P-value = 0.00232) of cellular component.  
A disease-related cluster (NCF2, CYBA, CYBB) 
involving in disease class, Immunological was gained 
from the candidate clusters of MCL with L(C) =1.0. 
The NCF2 is a causal gene of Chronic granulomatous 
disease due to deficiency of NCF-2, (OMIM ID: 233710), 
the CYBA causes Chronic granulomatous disease, auto-
somal, due to deficiency of CYBA (OMIM ID: 233690), 
and the CYBB is associated with Chronic granulomat-
ous disease, X-linked (OMIM ID: 306400). The cluster is 
also enriched with GO terms: superoxide anion gen-
eration (P-value = 6.44e-09), respiratory burst (P-value 
= 1.31e-08), superoxide metabolic process (P-value = 
3.77e-08)  of  biological  process,  and  superox-
ide-generating  NADPH  oxidase  activity  (P-value  = 
5.15e-06), electron carrier activity (P-value = 6.63e-06) 
of molecular function, and NADPH oxidase complex 
(P-value = 1.27e-09) of cellular component. 
 In Fig. 6A, the disease-related cluster consisting 
of  housekeeping  genes  (EIF2B2,  EIF2B3,  EIF2B4, 
EIF2B5, EIF2S2) is associated with Leukoencephalopathy 
with  vanishing  white  matte  and  Ovarioleukodystrophy 
(OMIM ID: 603896). The GO annotation indicates that 
this cluster takes part in biological process: oligoden-
drocyte development (P-value = 8.40e-11), oligoden-
drocyte differentiation (P-value = 2.41e-09), glial cell 
development (P-value = 3.40e-09), has same molecular 
function  in  translation  initiation  factor  activity 
(P-value = 6.84e-13), translation factor activity, nucleic 
acid  binding  (P-value  =  1.54e-11),  RNA  binding 
(P-value  = 6.93e-07),  and corresponds to  eukaryotic 
translation  initiation  factor  2B  complex  (P-value  = 
5.28e-14). 
Two disease-related clusters involving in BRCA1 
(breast cancer 1, early onset) and BRCA2 (breast can-
cer 2, early onset) were discovered. The BRCA1 is a 
causal  gene  of  Breast-ovarian  cancer,  Ovarian  cancer, 
Papillary  serous  carcinoma  of  the  peritoneum,  and  the 
BRCA2 is associated with Breast cancer, male, suscepti-
bility to  (OMIM  ID:  114480),  Fanconi anemia, comple-
mentation  group  D1  (OMIM  ID:  605724),  Pancreatic 
cancer  (OMIM  ID:  260350).  We  also  found  a  dis-
ease-related  cluster  involving  in  RAD51A  and 
RAD54L that are associated with several Breast Can-
cer  variants (RAD51A, Breast cancer, susceptibility to, 
OMIM  ID:  114480;  RAD54L,  Breast  cancer,  invasive 
intraductal), and two disease-related clusters, (BUB1B, 
BUBR1,  BUB1)  and  (MLH1,  PMS1,  MLH3,  MLH3, 
PMS2),  which  are  associated  with  several  Colorectal 
Cancer variants.  
Discussion 
Human  disease-related  gene  clus-
ters/subnetworks  are  of  great  importance  because 
they not only provide concrete hypotheses as to the 
molecular  complexes,  signaling  pathways,  but  also 
offer mechanistic hypotheses about the causes of dis-
ease [2]. With the development of biological experi-
ment methods, protein interactions and gene expres-
sion  data  are  becoming  more  and  more  complete, 
which  offer  valuable  biological  materials  for  dis-
ease-related clusters analysis. 
The  used  clustering  algorithms  such  as  CPM, 
MCODE and MCL were initially proposed to identify 
functional modules or protein complexes − groups of 
genes within which connections are dense while be-
tween which they are sparse, it is consistent with the 
characteristic of disease-related gene clusters of Goh 
et al. [2, 14, 15, 16] that disease genes causing similar Int. J. Biol. Sci. 2011, 7 
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diseases exhibit an increased tendency for their pro-
tein  products  to  interact  with  each  other.  We  used 
CPM, MCODE and MCL to decompose human PPI 
network into dense clusters as the candidates of dis-
ease-related clusters. It is analogous to Lage et al. [12] 
and  Fraser  et  al.  [13]  who  looked  for  protein  com-
plexes  whose  genes  were  associated  with  similar 
phenotypes and discovered large-scale disease genes.  
In  previous  studies,  many  methods  used  PPI 
networks to uncover novel disease-causing genes [2]. 
Lim et al. [7] built a PPI network around 23 proteins 
involved in inherited ataxias using Y2H screens, and 
used this network in uncovering novel ataxia-causing 
genes and genetic modifiers for ataxia. Pujana et al. [8] 
constructed a breast cancer-related network starting 
with four known breast cancer-associated genes for 
predicting new genes associated with breast cancer. 
Oti et al. [9] predicted new disease associated genes 
that fell within one of the significant loci and had a 
protein  interaction  with  a  gene  already  known  to 
cause  disease.  In  addition,  PPI  networks  were  also 
employed  for  disease  candidate  gene  prioritization. 
Franke et al. [10] used the known molecular interac-
tions  and  the  predicted  functional  relations  to  con-
struct a functional human gene network that was used 
to rank the candidate genes on the basis of their inte-
ractions. Chen et al. [11] described a candidate gene 
prioritization method that was entirely based on PPI 
network  analyses  and  successfully  used  for  disease 
candidate gene prioritization. Here, we can also pre-
dict  novel  disease-causing  genes  based  on  dis-
ease-related  gene  clusters.  Given  that  the  unknown 
disease  genes  also  cause  similar  disease  with  the 
known disease genes in the identified disease-related 
clusters, our method predicted 47 new disease genes 
(SEPT4,  UBB,  RASD1,  FBLN1,  GFRA1,  SCGB1A1, 
CFH,  C8A,  BF,  IFNG,  GATA4,  NKX2-5,  F3,  PLAU, 
PKN1, MAG, IGFALS, IGFBP3, IGFBP5, HSPA5, IL7, 
DIPA,  CYCS,  IL13RA1,  SPTAN1,  ABCD1,  ABCD2, 
C1R,  HRG,  PTX3,  CGA,  CGB,  EXO1,  PCNA,  C5 
MASP1, CD8B1, RSN, MSH4, ADD1, DLAT, PDK1, 
PDK2, RAC1, EIF2S2, TRAP1, FDX1, EVPL) from the 
disease-related clusters detected from the candidate 
clusters  of  CPM,  similarly,  49  new  disease  genes 
(SLC8A1,  DMC1,  RAD51AP1,  ERCC1,  BMP1,  DST, 
CGA,  CGB7,  ZC3H11A,  MBD4,  CRYZ,  KIRREL, 
KIRREL3,  TBX5,  BMPR1A,  BMPR2,  BMP6,  PCM1, 
KIAA0368, EDNRA, CTSG, DAPK3, F2RL3, GABRA4, 
AFAP,  HBZ,  RLN2,  HRG,  C1QB,  C1QG,  SLC4A7, 
COL5A3, NTHL1, TFPI2,  SHOC2,  PLCE1,  COL3A1, 
CHAD,  NDUFS6,  INSRR,  CHRNG,  PKD2,  EIF2S2, 
TRAP1, GALNT5, PHYH, DNM1L, DDO, SIRT3) of 
MCL.  3  new  disease  genes  (CGA,  EIF2S2,  TRAP1) 
were  in  both  of  the  above  two  disease  genes  sets. 
Here, we used the disease-related clusters to predict 
novel  disease-causing  genes,  it  not  only  considered 
the higher interaction with known disease genes, but 
also  the  higher  consistency  in  GO  annotations  and 
expression of human tissues, which can give us a be-
lievable prediction. 
In  our  paper,  the  clustering  algorithms,  CPM, 
MCODE and MCL for functional modules or protein 
complexes  detection  in  general  were  evaluated  by 
analyzing the consistency of genes or proteins within 
the  functional  modules  in  functional  annotations. 
Here,  we  evaluated  these  clustering  algorithms  by 
decomposing human PPI networks into dense clusters 
as  the  candidates  of  disease-related  clusters.  We 
found that the clusters decomposed by CPM outper-
formed MCL and MCODE as the candidates of dis-
ease-related  clusters  with  well-supported  biological 
significance in biological process, molecular function 
and cellular component of GO and expression of hu-
man tissues (see Table 2). In the leave-one-out cross 
validation  procedure,  our  method  obtained  better 
performance in using the disease-related clusters de-
tected from the candidate clusters of CPM than MCL, 
when  removed  one  known  disease gene  and  all its 
gene-disease  associations.  While  for  2≤k≤15,  MCL 
gained better results than CPM in Precision (see Fig. 2). 
It  is  because  the  size  of  disease-related  clusters  of 
CPM is smaller than MCL, when we removed known 
disease genes and all their gene-disease associations 
in  the  disease-related  clusters,  more  disease-related 
clusters‟ DisRC  declined  quickly  below  0.5  in  CPM 
than MCL, consequently, MCL performed better than 
CPM.  
In  conclusion,  we  integrated  known  disease 
genes with human PPI networks and gene expression 
data to identify disease-related clusters, and our me-
thod showed better performance. This study not only 
can help us understand disease mechanisms and infer 
new disease-causing genes, but also help us develop 
new diagnostics and therapeutics. In the future work, 
we  will  apply  our  approach  to  other  species  such 
yeast or fly for disease-related clusters‟ detection.  
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